PTAB Invalidates United Therapeutics Patent Relating To The Hypertension Drug - Tyvaso® - Patent

In Liquidia Techs., Inc. v. United Therapeutics Corp.,[1] the Patent Trial and Appeal Board ("the PTAB") held all challenged claims of U.S. Patent No. 10,716,793 ("the '793 patent") unpatentable under 35 U.S.C. § 103.

Related Keywords

,Liquidia Techs Inc ,Fox Factory Inc ,Liquidia Techs ,Patent Trial ,Appeal Board ,United Therapeutic ,Loreal United States ,Mondaq ,Ptab Invalidates United Therapeutics Patent Relating To The Hypertension Drug Tyvaso Xae ,Intellectual Property ,Patent ,